stalled on semaglutide GLP-1 stall: why your weight loss stopped and how to fix it Semaglutide Plateau: Why It Stops

Following the success of the SELECT trial, Wegovy (semaglutide in doses of 1.7 mg and 2.4 mg) received a similar approval in March 2024 for people with overweight or obesity and cardiovascular disease

Our team of specialists in St

The Med+ Program is for those who want access to prescription weight-loss medications alongside clinical oversight

Following FDA-approved titration schedules for each specific medication is essential

This GH therapy can have a range of effects, including increased muscle mass, improved recovery and repair from workouts, and enhanced fat metabolism

Animal studies have consistently demonstrated that GLP-1 receptor agonists reduce alcohol intake in rodent models of alcohol consumption